Modulation of experimental systemic lupus erythematosus.
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
E
E
Mozes
R
R
Segal
Z
Z
Sthoeger
M
M
Dayan
H
H
Zinger
L D
LD
Kohn
D S
DS
Singer
D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D013629:Tamoxifen / Q000627:therapeutic use
D018501:Antirheumatic Agents; D004965:Estrogen Antagonists; D000949:Histocompatibility Antigens Class II; D013629:Tamoxifen; D008713:Methimazole; D008727:Methotrexate